General Information of Drug (ID: DMFRZGS)

Drug Name
3-(4-methoxybenzyloxy)-2-phenylthiazolidin-4-one
Synonyms CHEMBL386837; 921611-05-4; 3-(4-methoxybenzyloxy)-2-phenylthiazolidin-4-one; CTK3H0752; DTXSID80658821; BDBM50198253; AKOS030552092; 4-Thiazolidinone, 3-[(4-methoxyphenyl)methoxy]-2-phenyl-
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 315.4
Logarithm of the Partition Coefficient (xlogp) 3.3
Rotatable Bond Count (rotbonds) 5
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C17H17NO3S
IUPAC Name
3-[(4-methoxyphenyl)methoxy]-2-phenyl-1,3-thiazolidin-4-one
Canonical SMILES
COC1=CC=C(C=C1)CON2C(SCC2=O)C3=CC=CC=C3
InChI
InChI=1S/C17H17NO3S/c1-20-15-9-7-13(8-10-15)11-21-18-16(19)12-22-17(18)14-5-3-2-4-6-14/h2-10,17H,11-12H2,1H3
InChIKey
IUBPXBYZGYCTMU-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
44418200
CAS Number
921611-05-4
TTD ID
D0XB2Z

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Voltage-gated potassium channel Kv1.5 (KCNA5) TTW0CMT KCNA5_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Evolution of thiazolidine-based blockers of human Kv1.5 for the treatment of atrial arrhythmias. Bioorg Med Chem Lett. 2007 Jan 1;17(1):282-4.